Tuan Tu Diep's most recent trade in Skye Bioscience Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 22,021 | 22,021 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 22,021 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 9,194 | 9,194 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 9,194 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 8,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 7,080 | 7,080 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2026 | 7,080 | 0 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 19,489 | 82,259 (0%) | 0% | 5.0 | 97,250 | Common Stock |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 85 | 101,748 (0%) | 0% | 5.6 | 472 | Common Stock |
| Skye Bioscience Inc | Tuan Tu Diep | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |